Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age35+
SponsorSeung-Jung Park
About this trial
About 20,000 patients with FFR (Fractional Flow Reserve) will be enrolled and evaluated for the natural history of coronary lesions at 2 years clinical and imaging follow-up.
Eligibility criteria
Qualifiers
Age 35 years and older
FFR measurement on one and more coronary artery stenosis
Willing and able to provide informed, written consent
Disqualifiers
Stenosis with TIMI<3 flow
Graft vessel
Ejection fraction < 30%
Angiographic evidence of extreme tortuosity or calcified coronary vessels
Trial design
Treatments tested in this trial
- Not listed
Trial groups
20,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
CardioVascular Research Foundation, Korea
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Abbott Medical Devices
Collaborator
Source ClinicalTrials.gov